[Antimitotic activity of prospidin].
D000433:1-Propanol / Q000627:therapeutic use; D000818:Animals; D000970:Antineoplastic Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D001853:Bone Marrow / Q000187:drug effects; D001854:Bone Marrow Cells; D003315:Cornea / Q000187:drug effects; D007274:Injections, Intraperitoneal; D008297:Male; D008938:Mitosis / Q000187:drug effects*; D010879:Piperazines / Q000627:therapeutic use*; D051381:Rats; D012513:Sarcoma, Experimental / Q000188:drug therapy*; D013141:Spiro Compounds / Q000627:therapeutic use*
D000970:Antineoplastic Agents; D010879:Piperazines; D013141:Spiro Compounds; D000433:1-Propanol
Ob antimitoticheskoĭ aktivnosti prospidina.